CSL Limited: Temporary Headwinds for a Long-Term Healthcare Leader

VinhVu

Not Invested

Community Contributor

Published

08 Mar 26

Views

399

n/a

VinhVu's Fair Value

n/a

-59.2%

-20.3%

-59.2%

-20.3%

You can edit this narrative until Mar 9 6:55 AM. Then, changes will post as Updates.

Author's Valuation

AU$254.1161.7% undervalued

VinhVu's Fair Value

Valuator

Company Info

Notes

VinhVu'sFair Value

AU$254.11

61.7% undervalued

Future estimation in

Revenue

Profit Margin

Future PE

Growth p.a.

Decrease

Increase

Forecast revenue growth rate

3.39%

Historical revenue growth rate

10.56%

Biotech revenue growth rate

9.13%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.46%

Calculation

US$3.23b

Earnings '31

37.00x

PE Ratio '31

US$119.35b

Market Cap '31

US$119.35b

Market Cap '31

471.86m

No. shares '31

US$252.94

Share Price '31

US$252.94 Share Price '31

Discounted to 2026 @ 7.27% p.a.

US$178.11

Fair Value '26

US$178.11 Fair Value '26

Converted to AUD @ 1.4236 USD/AUD Exchange Rate

AU$253.56

Fair Value '26